NOS3 and obesity due to melanocortin 4 receptor deficiency: Indeed, in rodent models of obesity, several pharmaceuticals [e.g., metformin (49), resveratrol (50), and methotrexate (51)] are reported to reduce pro-inflammatory cytokine expression in AT and promote adiponectin expression, thereby rescuing eNOS phosphorylation and endothelial function.